Ryesino Pharmaceuticals Private Limited

Ryesino Pharmaceuticals Private Limited - pharma in Uttar Pradesh, India. FY 2026 financials & compliance.
CIN U85110UP1983PTC006356 Incorporated 15 December 1983 ROC Uttar Pradesh HQ Uttar Pradesh, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2024
₹14.49 Cr
▲ 11% YoY
Net profit · FY 2024
₹43.98 Lakh
Net margin 3%
EBITDA · FY 2024
₹54.04 Lakh
EBITDA margin 3.7%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹8.28 Lakh
Issued & subscribed
Open charges
₹76.45 Lakh
Satisfied ₹95 Lakh
Company age
43 yrs
Est. 1983
Directors on board
4
As per MCA filings

About Ryesino Pharmaceuticals Private Limited

Data last updated:

Ryesino Pharmaceuticals Private Limited is a private limited company based in Uttar Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 December 1983 and has been in existence for over 43 years.

The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U85110UP1983PTC006356. Its GSTIN is 05AACCR7809R1ZR (Uttarakhand). The company holds 2 GST registrations, of which 1 is active.

The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹8.28 Lakh. It is led by directors including Jaidesh Pal Wason (Managing Director) and Renu Wason.

Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 3 B Race Course Dehradun, Uttar Pradesh, India – 248001.

As per the financials filed for FY 2024, the company reported a revenue of ₹14.49 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹43.98 Lakh (net margin 3%) and EBITDA of ₹54.04 Lakh (EBITDA margin 3.7%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 4% over five years.

As per MCA filings, the company has open charges of ₹76.45 Lakh and satisfied charges of ₹95 Lakh on record.

Ryesino Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0016782). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website rinkomedicos.com.

Company details

CIN U85110UP1983PTC006356
Registration Number 006356
Incorporation Date 15 December 1983
ROC Uttar Pradesh
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-UK-05-0016782

CIN history

Ryesino Pharmaceuticals has one previous CIN (Corporate Identification Number): U85110UR1983PTC006356. The current CIN is U85110UP1983PTC006356, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U85110UP1983PTC006356Current
U85110UR1983PTC006356Previous

Recognitions & Rankings of Ryesino Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Small (2023-24)
Udyam number
UDYAM-UK-05-0016782

Contact details

Ryesino Pharmaceuticals Private Limited's registered office is in Uttar Pradesh. Its website is rinkomedicos.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    3 B Race Course Dehradun, Uttar Pradesh, India – 248001
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Ryesino Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Ryesino Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Ryesino Pharmaceuticals is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Ryesino Pharmaceuticals Private Limited, buy the company report.

Financials of Ryesino Pharmaceuticals Private Limited

FY 2025 filings available

Ryesino Pharmaceuticals Private Limited reported revenue of ₹14.49 Cr (up 11% YoY) for FY 2024.

Revenue · FY 2024
₹14.49 Cr ▲ 11%
Net profit · FY 2024
₹43.98 Lakh margin 3%
EBITDA · FY 2024
₹54.04 Lakh margin 3.7%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▲ 6%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 1%
5 years · compounded
▲ 19%

Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 11% growth in the latest year. EBITDA fell 12% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹54.04 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹43.98 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin3.7%
Net Profit Margin3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Ryesino Pharmaceuticals Private Limited, buy the company report.

Board of directors of Ryesino Pharmaceuticals Private Limited

Ryesino Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Jaidesh Pal WasonManaging Director15 Dec 198342 Years 11 MonthsCurrent
Renu WasonDirector18 Dec 198639 Years 10 MonthsCurrent
Sachin WasonDirector27 Mar 200026 Years 7 MonthsCurrent
Shagun WasonDirector01 Jun 200323 Years 5 MonthsCurrent

Peer comparison

Ryesino Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sredstva Regionale Chemie Private Limited₹14.53 Cr (FY 2024)-10.0%Mumbai, Maharashtra, India
Ryesino Pharmaceuticals Private Limitedthis company₹14.49 Cr (FY 2024)₹43.98 Lakh3%11.0%Uttar Pradesh, India
Elma Pharmaceuticals Private Limited₹14.46 Cr (FY 2025)1.0%Thrissur, Kerala, India
Shree Raghupati Trading Private Limited₹14.44 Cr (FY 2024)11.0%Lucknow, Uttar Pradesh, India
Bda Pharma Private Limited₹14.34 Cr (FY 2025)-16.0%Nagpur, Maharashtra, India

To see the full peer comparison of Ryesino Pharmaceuticals Private Limited, buy the company report.

Auditor

Ryesino Pharmaceuticals Private Limited is audited by NEERAJNAGALIA for the financial year 2022.

Auditor firmFinancial yearFirm registration number
NEERAJNAGALIAFY 2022070978

Shareholding

The shareholding of Ryesino Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019FY 2018
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Ryesino Pharmaceuticals Private Limited, buy the company report.

Charges & borrowings

Open charges
₹76.45 Lakh
Satisfied charges
₹95 Lakh
Breakdown by lending institutions
State Bank of India₹0.65 Cr
Others₹0.12 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
20 Aug 2025101155673Others₹11.95 LakhOpen
18 Nov 200590281085State Bank of India₹60 LakhOpen
08 Sep 200090272357State Bank of India₹4.5 LakhOpen
22 May 200710053997State Bank of India₹95 LakhSatisfied

To see the full charge records of Ryesino Pharmaceuticals Private Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Ryesino Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Ryesino Pharmaceuticals has 2 GST registrations: 1 active and 1 cancelled or inactive.

Total GSTINs
2
Active
1
Cancelled / inactive
1
GSTINStateStatusRegistered on
05AACCR7809R1ZRUttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Ryesino Pharmaceuticals Private Limited, buy the company report.

Recent activity

Ryesino Pharmaceuticals Private Limited has 7 board changes on record since 1983: 4 appointments and 3 cessations. The latest: Meena Wason ceased to be Director on 15 Apr 2019.

AGM
Ryesino Pharmaceuticals Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 11.95 Lakh with Charge ID 101155673 was registered on 20 Aug 2025.
Filing
Ryesino Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh I.
Charges
A charge registered on 22 May 2007 via Charge ID 10053997 with State Bank Of India was fully satisfied on 17 Aug 2023.
Ceased
Meena Wason ceased to be Director.
Ceased
Suresh Kumar Wason ceased to be Director.
Ceased
Tarun Wason ceased to be Director.
Charges
A charge with State Bank Of India of Rs. 95.00 Lakh registered on 22 May 2007 with Charge ID 10053997 was modified on 18 Sep 2014.
Charges
A charge with State Bank Of India amounted to Rs. 95.00 Lakh with Charge ID 10053997 was registered on 22 May 2007.
Charges
A charge with State Bank Of India amounted to Rs. 60.00 Lakh with Charge ID 90281085 was registered on 18 Nov 2005.
Appointed
Shagun Wason was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 4.50 Lakh registered on 08 Sep 2000 with Charge ID 90272357 was modified on 21 Jan 2003.

5 earlier events are in the company report.

Frequently asked questions

Ryesino Pharmaceuticals is an active private limited company based in Uttar Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 December 1983 (43+ years old) and is registered under CIN U85110UP1983PTC006356.

Ryesino Pharmaceuticals has 4 current directors:

The latest financial statements of Ryesino Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Ryesino Pharmaceuticals is 05AACCR7809R1ZR, registered in Uttarakhand. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.

The CIN (Corporate Identification Number) of Ryesino Pharmaceuticals is U85110UP1983PTC006356. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Ryesino Pharmaceuticals was incorporated on 15 December 1983, making it 43+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.

The peers of Ryesino Pharmaceuticals by revenue are Sredstva Regionale Chemie Private Limited, Elma Pharmaceuticals Private Limited, Shree Raghupati Trading Private Limited, Bda Pharma Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).

Meena Wason ceased to be Director on 15 Apr 2019. Suresh Kumar Wason ceased to be Director on 15 Apr 2019. Tarun Wason ceased to be Director on 15 Apr 2019. Ryesino Pharmaceuticals has 7 board changes on record in total.

Yes, Ryesino Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-UK-05-0016782).

Ryesino Pharmaceuticals can be reached through the website rinkomedicos.com. Its registered office is in Uttar Pradesh, India.

The registered office of Ryesino Pharmaceuticals is at 3 B Race Course Dehradun, Uttar Pradesh, India – 248001.